← Leaderboards
Dario C. Altieri
Wistar Institute
$49,807,901
Attributed
$50,171,178
Total exposure
34
Grants
32
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$107,215,567 · 36
By mechanism
P30$64,203,783 · 20
P01$18,099,546 · 6
R01$14,046,613 · 7
R35$7,658,576 · 1
R37$3,084,424 · 1
R21$122,625 · 1
Top collaborators
- Anthony J. Olszanski2 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsProgramsMemberBasic Cancer ResearchFundingCancer CenterCancer Research ProjectResource SharingCollaborationsPublicationsAnticancer ResearchResearch PersonnelBudgetsMolecularGrantAreaPathway InteractionsNeoplasm MetastasisCancer Center Support GrantTumorBaseLeadershipGrowthDesign
Grant awards (200)
Consolidated Basic Cancer Research Program$2,833,735
P30 · FY2025 · CA · contact PI
Parkin tumor suppression$499,626
R01 · FY2025 · CA · contact PI
Developmental Funds$459,436
P30 · FY2025 · CA · contact PI
Cancer Center Administration$449,039
P30 · FY2025 · CA · contact PI
Leadership, Planning and Evaluation$210,361
P30 · FY2025 · CA · contact PI
Consolidated Basic Cancer Research Program$2,833,735
P30 · FY2024 · CA · contact PI
Immunological approaches to overcoming therapy resistance in human tumors$749,999
P30 · FY2024 · CA · contact PI
Parkin tumor suppression$499,626
R01 · FY2024 · CA · contact PI
Consolidated Basic Cancer Research Program$2,714,982
P30 · FY2023 · CA · contact PI
Tumor Plasticity$1,117,200
R35 · FY2023 · CA · contact PI
Cancer Center Administration$418,228
P30 · FY2023 · CA · contact PI
Developmental Funds$399,936
P30 · FY2023 · CA · contact PI
Consolidated Basic Cancer Research Program$249,893
P30 · FY2023 · CA · contact PI
Leadership, Planning and Evaluation$157,932
P30 · FY2023 · CA · contact PI
Consolidated Basic Cancer Research Program$2,714,982
P30 · FY2022 · CA · contact PI
Tumor Plasticity$1,117,200
R35 · FY2022 · CA · contact PI
Cancer Center Administration$418,228
P30 · FY2022 · CA · contact PI
Developmental Funds$399,936
P30 · FY2022 · CA · contact PI
A First-in-Human Phase I Clinical Trial of Mitochondrial-Targeted Hsp90 Inhibitor, Gamitrinib$316,269
R01 · FY2022 · CA · contact PI
Leadership, Planning and Evaluation$157,932
P30 · FY2022 · CA · contact PI
Augmenting T-cell immunotherapy outcomes in blood and solid tumor microenvironment in ART-suppressed HIV infection (immune/microenvironment)$124,157
P30 · FY2022 · CA · contact PI
Consolidated Basic Cancer Research Program$2,714,982
P30 · FY2021 · CA · contact PI
Tumor Plasticity$1,140,000
R35 · FY2021 · CA · contact PI
Cancer Center Administration$418,228
P30 · FY2021 · CA · contact PI
A First-in-Human Phase I Clinical Trial of Mitochondrial-Targeted Hsp90 Inhibitor, Gamitrinib$410,285
R01 · FY2021 · CA · contact PI
Developmental Funds$399,936
P30 · FY2021 · CA · contact PI
Leadership, Planning and Evaluation$157,932
P30 · FY2021 · CA · contact PI
Novel Molecular Therapies of Prostate Cancer$85,800
P01 · FY2021 · CA · contact PI
Consolidated Basic Cancer Research Program$2,719,954
P30 · FY2020 · CA · contact PI
Novel Molecular Therapies of Prostate Cancer$1,208,002
P01 · FY2020 · CA · contact PI
Tumor Plasticity$1,140,000
R35 · FY2020 · CA · contact PI
Cancer Center Administration$490,175
P30 · FY2020 · CA · contact PI
Developmental Funds$371,170
P30 · FY2020 · CA · contact PI
Project 1 - Mitochondrial reprogramming in prostate cancer metastasis$291,993
P01 · FY2020 · CA · contact PI
Core A - Administration and Biostatistics$161,628
P01 · FY2020 · CA · contact PI
Leadership, Planning and Evaluation$146,652
P30 · FY2020 · CA · contact PI
Consolidated Basic Cancer Research Program$104,776
P30 · FY2020 · CA · contact PI
Consolidated Basic Cancer Research Program$100,000
P30 · FY2020 · CA · contact PI
Consolidated Basic Cancer Research Program$2,749,311
P30 · FY2019 · CA · contact PI
Novel Molecular Therapies of Prostate Cancer$1,179,015
P01 · FY2019 · CA · contact PI
Tumor Plasticity$1,104,176
R35 · FY2019 · CA · contact PI
Cancer Center Administration$432,905
P30 · FY2019 · CA · contact PI
Developmental Funds$419,586
P30 · FY2019 · CA · contact PI
Project 1 - Mitochondrial reprogramming in prostate cancer metastasis$265,446
P01 · FY2019 · CA · contact PI
Leadership, Planning and Evaluation$157,932
P30 · FY2019 · CA · contact PI
Core A - Administration and Biostatistics$141,689
P01 · FY2019 · CA · contact PI
Cancer Center Administration$93,642
P30 · FY2019 · CA · contact PI
Consolidated Basic Cancer Research Program$93,642
P30 · FY2019 · CA · contact PI
Program Integration and Management$86,831
P01 · FY2019 · CA · contact PI
Consolidated Basic Cancer Research Program$2,645,581
P30 · FY2018 · CA · contact PI
Novel Molecular Therapies of Prostate Cancer$1,222,825
P01 · FY2018 · CA · contact PI
Tumor Plasticity$1,140,000
R35 · FY2018 · CA · contact PI
Developmental Funds$505,004
P30 · FY2018 · CA · contact PI
Administration$451,255
P30 · FY2018 · CA · contact PI
Animal Facility Shared Resources$283,638
P30 · FY2018 · CA · contact PI
Project 1 - Mitochondrial reprogramming in prostate cancer metastasis$274,181
P01 · FY2018 · CA · contact PI
Bioinformatics Shared Resources$239,651
P30 · FY2018 · CA · contact PI
Genomics$231,911
P30 · FY2018 · CA · contact PI
Molecular Screening Shared Resource$200,415
P30 · FY2018 · CA · contact PI
Consolidated Basic Cancer Research Program$200,000
P30 · FY2018 · CA · contact PI
Proteomics Shared Resource$199,516
P30 · FY2018 · CA · contact PI
Senior Leadership$165,223
P30 · FY2018 · CA · contact PI
Core A - Administration and Biostatistics$146,596
P01 · FY2018 · CA · contact PI
Consolidated Basic Cancer Research Program$142,498
P30 · FY2018 · CA · contact PI
Flow Cytometry$126,230
P30 · FY2018 · CA · contact PI
Program Integration and Management$90,041
P01 · FY2018 · CA · contact PI
PROTEIN EXPRESSION SHARED RESOURCE$87,685
P30 · FY2018 · CA · contact PI
IMAGING SHARED RESOURCE$68,182
P30 · FY2018 · CA · contact PI
Gene Expression$27,827
P30 · FY2018 · CA · contact PI
Molecular and Cellular Oncogenesis$23,085
P30 · FY2018 · CA · contact PI
Planning and Evaluation$20,172
P30 · FY2018 · CA · contact PI
Tumor Microenvironment and Metastasis$15,787
P30 · FY2018 · CA · contact PI
Animal Facility Shared Resources$13,334
P30 · FY2018 · CA · contact PI
IMAGING SHARED RESOURCE$13,334
P30 · FY2018 · CA · contact PI
Gene Expression$13,334
P30 · FY2018 · CA · contact PI
Molecular and Cellular Oncogenesis$13,334
P30 · FY2018 · CA · contact PI
Tumor Microenvironment and Metastasis$13,334
P30 · FY2018 · CA · contact PI
Molecular Screening Shared Resource$13,333
P30 · FY2018 · CA · contact PI
Proteomics Shared Resource$13,333
P30 · FY2018 · CA · contact PI
Genomics$13,333
P30 · FY2018 · CA · contact PI
Bioinformatics Shared Resources$13,333
P30 · FY2018 · CA · contact PI
PROTEIN EXPRESSION SHARED RESOURCE$13,333
P30 · FY2018 · CA · contact PI
Administration$13,333
P30 · FY2018 · CA · contact PI
Developmental Funds$13,333
P30 · FY2018 · CA · contact PI
Planning and Evaluation$13,333
P30 · FY2018 · CA · contact PI
Senior Leadership$13,333
P30 · FY2018 · CA · contact PI
Flow Cytometry$13,333
P30 · FY2018 · CA · contact PI
IMAGING SHARED RESOURCE$9,500
P30 · FY2018 · CA · contact PI
Gene Expression$9,500
P30 · FY2018 · CA · contact PI
Molecular and Cellular Oncogenesis$9,500
P30 · FY2018 · CA · contact PI
Tumor Microenvironment and Metastasis$9,500
P30 · FY2018 · CA · contact PI
Animal Facility Shared Resources$9,500
P30 · FY2018 · CA · contact PI
Flow Cytometry$9,500
P30 · FY2018 · CA · contact PI
Senior Leadership$9,500
P30 · FY2018 · CA · contact PI
Planning and Evaluation$9,500
P30 · FY2018 · CA · contact PI
Developmental Funds$9,500
P30 · FY2018 · CA · contact PI
Administration$9,500
P30 · FY2018 · CA · contact PI
PROTEIN EXPRESSION SHARED RESOURCE$9,500
P30 · FY2018 · CA · contact PI
Bioinformatics Shared Resources$9,500
P30 · FY2018 · CA · contact PI
Genomics$9,500
P30 · FY2018 · CA · contact PI
Molecular Screening Shared Resource$9,500
P30 · FY2018 · CA · contact PI
Proteomics Shared Resource$9,498
P30 · FY2018 · CA · contact PI
Consolidated Basic Cancer Research Program$2,645,581
P30 · FY2017 · CA · contact PI
Novel Molecular Therapies of Prostate Cancer$1,239,835
P01 · FY2017 · CA · contact PI
Tumor Plasticity$900,000
R35 · FY2017 · CA · contact PI
Developmental Funds$454,504
P30 · FY2017 · CA · contact PI
Administration$406,130
P30 · FY2017 · CA · contact PI
Control of Apoptosis in Cancer by Survivin$380,000
R01 · FY2017 · CA · contact PI
Project 1 - Mitochondrial reprogramming in prostate cancer metastasis$276,329
P01 · FY2017 · CA · contact PI
Animal Facility Shared Resources$255,274
P30 · FY2017 · CA · contact PI
Control of Apoptosis in Cancer by Survivin$228,000
R01 · FY2017 · CA · contact PI
Bioinformatics Shared Resources$215,687
P30 · FY2017 · CA · contact PI
Genomics$208,721
P30 · FY2017 · CA · contact PI
Molecular Screening Shared Resource$180,375
P30 · FY2017 · CA · contact PI
Proteomics Shared Resource$179,565
P30 · FY2017 · CA · contact PI
Core A - Administration and Biostatistics$148,744
P01 · FY2017 · CA · contact PI
Senior Leadership$148,700
P30 · FY2017 · CA · contact PI
Consolidated Basic Cancer Research Program$142,498
P30 · FY2017 · CA · contact PI
Flow Cytometry$113,606
P30 · FY2017 · CA · contact PI
Program Integration and Management$92,188
P01 · FY2017 · CA · contact PI
PROTEIN EXPRESSION SHARED RESOURCE$78,918
P30 · FY2017 · CA · contact PI
IMAGING SHARED RESOURCE$61,364
P30 · FY2017 · CA · contact PI
Gene Expression$25,041
P30 · FY2017 · CA · contact PI
Molecular and Cellular Oncogenesis$20,776
P30 · FY2017 · CA · contact PI
Planning and Evaluation$18,155
P30 · FY2017 · CA · contact PI
Tumor Microenvironment and Metastasis$14,207
P30 · FY2017 · CA · contact PI
Consolidated Basic Cancer Research Program$2,645,581
P30 · FY2016 · CA · contact PI
Novel Molecular Therapies of Prostate Cancer$1,272,322
P01 · FY2016 · CA · contact PI
Developmental Funds$472,141
P30 · FY2016 · CA · contact PI
Administration$423,767
P30 · FY2016 · CA · contact PI
(PQC2) Plasticity Of The.PI3K Network In Early Dormancy$394,250
R01 · FY2016 · CA · contact PI
Control of Apoptosis in Cancer by Survivin$380,000
R01 · FY2016 · CA · contact PI
Animal Facility Shared Resources$272,911
P30 · FY2016 · CA · contact PI
Bioinformatics Shared Resources$233,324
P30 · FY2016 · CA · contact PI
Genomics$226,358
P30 · FY2016 · CA · contact PI
Project 1 - Mitochondrial reprogramming in prostate cancer metastasis$212,054
P01 · FY2016 · CA · contact PI
Core A - Administration and Biostatistics$212,054
P01 · FY2016 · CA · contact PI
Program Integration and Management$212,052
P01 · FY2016 · CA · contact PI
Molecular Screening Shared Resource$198,012
P30 · FY2016 · CA · contact PI
Proteomics Shared Resource$197,203
P30 · FY2016 · CA · contact PI
Senior Leadership$166,337
P30 · FY2016 · CA · contact PI
Consolidated Basic Cancer Research Program$142,498
P30 · FY2016 · CA · contact PI
Flow Cytometry$131,243
P30 · FY2016 · CA · contact PI
PROTEIN EXPRESSION SHARED RESOURCE$96,555
P30 · FY2016 · CA · contact PI
IMAGING SHARED RESOURCE$79,001
P30 · FY2016 · CA · contact PI
Gene Expression$42,680
P30 · FY2016 · CA · contact PI
Molecular and Cellular Oncogenesis$38,413
P30 · FY2016 · CA · contact PI
Planning and Evaluation$35,792
P30 · FY2016 · CA · contact PI
Tumor Microenvironment and Metastasis$31,844
P30 · FY2016 · CA · contact PI
Consolidated Basic Cancer Research Program$2,578,347
P30 · FY2015 · CA · contact PI
Developmental Funds$459,887
P30 · FY2015 · CA · contact PI
Administration$412,774
P30 · FY2015 · CA · contact PI
(PQC2) Plasticity Of The.PI3K Network In Early Dormancy$383,875
R01 · FY2015 · CA · contact PI
Control of Apoptosis in Cancer by Survivin$370,000
R01 · FY2015 · CA · contact PI
Animal Facility Shared Resources$265,887
P30 · FY2015 · CA · contact PI
Bioinformatics Shared Resources$227,343
P30 · FY2015 · CA · contact PI
Genomics$220,560
P30 · FY2015 · CA · contact PI
Molecular Screening Shared Resource$192,960
P30 · FY2015 · CA · contact PI
Proteomics Shared Resource$192,173
P30 · FY2015 · CA · contact PI
Senior Leadership$162,117
P30 · FY2015 · CA · contact PI
Consolidated Basic Cancer Research Program$138,748
P30 · FY2015 · CA · contact PI
Flow Cytometry$127,947
P30 · FY2015 · CA · contact PI
PROTEIN EXPRESSION SHARED RESOURCE$94,173
P30 · FY2015 · CA · contact PI
IMAGING SHARED RESOURCE$77,079
P30 · FY2015 · CA · contact PI
Gene Expression$41,715
P30 · FY2015 · CA · contact PI
Molecular and Cellular Oncogenesis$37,560
P30 · FY2015 · CA · contact PI
Planning and Evaluation$35,008
P30 · FY2015 · CA · contact PI
Tumor Microenvironment and Metastasis$31,164
P30 · FY2015 · CA · contact PI
Consolidated Basic Cancer Research Program$2,516,380
P30 · FY2014 · CA · contact PI
Novel Molecular Therapies of Prostate Cancer$1,197,703
P01 · FY2014 · CA · contact PI
Developmental Funds$446,848
P30 · FY2014 · CA · contact PI
Administration$400,850
P30 · FY2014 · CA · contact PI
(PQC2) Plasticity Of The.PI3K Network In Early Dormancy$383,875
R01 · FY2014 · CA · contact PI
Control of Apoptosis in Cancer by Survivin$370,000
R01 · FY2014 · CA · contact PI
Animal Facility Shared Resources$258,701
P30 · FY2014 · CA · contact PI
Bioinformatics Shared Resources$221,406
P30 · FY2014 · CA · contact PI
Genomics$214,843
P30 · FY2014 · CA · contact PI
Molecular Screening Shared Resource$188,133
P30 · FY2014 · CA · contact PI
Proteomics Shared Resource$187,370
P30 · FY2014 · CA · contact PI
Senior Leadership$158,283
P30 · FY2014 · CA · contact PI
Flow Cytometry$125,212
P30 · FY2014 · CA · contact PI
Consolidated Basic Cancer Research Program$92,630
P30 · FY2014 · CA · contact PI
PROTEIN EXPRESSION SHARED RESOURCE$92,533
P30 · FY2014 · CA · contact PI
IMAGING SHARED RESOURCE$75,861
P30 · FY2014 · CA · contact PI
Gene Expression$41,765
P30 · FY2014 · CA · contact PI
Molecular and Cellular Oncogenesis$37,745
P30 · FY2014 · CA · contact PI
Planning and Evaluation$35,276
P30 · FY2014 · CA · contact PI
Tumor Microenvironment and Metastasis$31,554
P30 · FY2014 · CA · contact PI
Consolidated Basic Cancer Research Program$2,308,335
P30 · FY2013 · CA · contact PI
Novel Molecular Therapies of Prostate Cancer$1,131,982
P01 · FY2013 · CA · contact PI
Mitochondrial Hsp90 chaperones and prostate cancer therapy$497,511
P01 · FY2013 · CA · contact PI
Molecular Pathology of Vascular Injury$369,138
R37 · FY2013 · HL · contact PI
Rational Design and Clinical Development of Shepherdin: A Novel Anti-Cancer Agent$325,422
R01 · FY2013 · CA · contact PI
Control of Apoptosis in Cancer by Survivin$287,949
R01 · FY2013 · CA · contact PI
Consolidated Basic Cancer Research Program$116,998
P30 · FY2013 · CA · contact PI
CURE Supplement$116,998
P30 · FY2013 · CA · contact PI
Administration and Biostatistics$32,680
P01 · FY2013 · CA · contact PI
Consolidated Basic Cancer Research Program$2,516,654
P30 · FY2012 · CA · contact PI
Novel Molecular Therapies of Prostate Cancer$1,216,100
P01 · FY2012 · CA · contact PI
Mitochondrial Hsp90 chaperones and prostate cancer therapy$512,491
P01 · FY2012 · CA · contact PI